Metacognitive Therapy Compared to Cognitive-behavioral Therapy

Starting soon · Not applicable

Conditions studied: Generalized Anxiety Disorder, Social Anxiety Disorder, Posttraumatic Stress Disorder (PTSD)

In brief

This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.

Key facts

Study ID

NCT07382323

Run by

Karolinska Institutet

People needed

30

Starts

2026-02-01

Expected to finish

2026-12-01

Last updated by the study team

2026-02-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older,
• A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder,
• No change in dose during the last six weeks if on pharmacological treatment, and
• Ability to read and speak Swedish.

You may not qualify if…

• A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder,
• Acute suicide risk, or
• Concurrent psychological treatment.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.